Related references
Note: Only part of the references are listed.Solid-Phase Synthesis of PEGylated Lipopeptides Using Click Chemistry
Rasmus I. Jolck et al.
BIOCONJUGATE CHEMISTRY (2010)
Liposomal cancer therapy: exploiting tumor characteristics
Thomas Kaasgaard et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Design and Evaluation of Doxorubicin-containing Microbubbles for Ultrasound-triggered Doxorubicin Delivery: Cytotoxicity and Mechanisms Involved
Ine Lentacker et al.
MOLECULAR THERAPY (2010)
Rational design of cationic lipids for siRNA delivery
Sean C. Semple et al.
NATURE BIOTECHNOLOGY (2010)
Drug Delivery by an Enzyme-Mediated Cyclization of a Lipid Prodrug with Unique Bilayer-Formation Properties
Lars Linderoth et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Release of Liposomal Contents by Cell-Secreted Matrix Metalloproteinase-9
Jayati Banerjee et al.
BIOCONJUGATE CHEMISTRY (2009)
Liposomes containing alkylated methotrexate analogues for phospholipase A2 mediated tumor targeted drug delivery
Thomas Kaasgaard et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes
Avi Schroeder et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2009)
A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo
Hiroto Hatakeyama et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Synthesis and Biophysical Characterization of Chlorambucil Anticancer Ether Lipid Prodrugs
Palle J. Pedersen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Design of liposomes containing photopolymerizable phospholipids for triggered release of contents
Amichai Yavlovich et al.
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY (2009)
Liposomes in ultrasonic drug and gene delivery
Shao-Ling Huang
ADVANCED DRUG DELIVERY REVIEWS (2008)
Design of Folate-Linked Liposomal Doxorubicin to its Antitumor Effect in Mice
Atsushi Yamada et al.
CLINICAL CANCER RESEARCH (2008)
Anti body-targeted liposomes in cancer therapy and imaging
Stavroula Sofou et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9
Adekunle I. Elegbede et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Targeting cancer with bugs and liposomes: Ready, aim, fire
Ian Cheong et al.
CANCER RESEARCH (2007)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
Hiroto Hatakeyama et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2007)
Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action
Samuel Zalipsky et al.
JOURNAL OF DRUG TARGETING (2007)
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
H. Hatakeyama et al.
GENE THERAPY (2007)
A bacterial protein enhances the release and efficacy of liposomal cancer drugs
Ian Cheong et al.
SCIENCE (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Domain-induced activation of human phospholipase A2 type IIA:: Local versus global lipid composition
C Leidy et al.
BIOPHYSICAL JOURNAL (2006)
Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting
T Terada et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Reduced toxicity and superior therapeutic activity of a mitomycin C lipid-based prodrug incorporated in pegylated liposomes
AA Gabizon et al.
CLINICAL CANCER RESEARCH (2006)
Synthesis and biological activity of anticancer ether lipids that are specifically released by phospholipase A2 in tumor tissue
TL Andresen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Matrix metalloproteinases as therapeutic targets in cancer
P Vihinen et al.
CURRENT CANCER DRUG TARGETS (2005)
Gelatinases (MMP-2 and-9) and their natural inhibitors as prognostic indicators in solid cancers
T Turpeenniemi-Hujanen
BIOCHIMIE (2005)
Uncorking of liposomes by matrix metalloproteinase-9
NR Sarkar et al.
CHEMICAL COMMUNICATIONS (2005)
Recent advances in tumor-targeting anticancer drug conjugates
S Jaracz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates
A Gabizon et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs
TL Andresen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Synthesis of anti-tumour phosphatidylinositol analogues from glucose by the use of ring-closing olefin metathesis
TL Andresen et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2004)
Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids
J Shin et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Phospholipase A2 expression in tumours:: a target for therapeutic intervention?
JP Laye et al.
DRUG DISCOVERY TODAY (2003)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
Effect of liposomal delivery on in vitro antitumor activity of lipophilic conjugates of methotrexate with lipoamino acids
R Pignatello et al.
DRUG DELIVERY (2003)
Secreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissue
J Davidsen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
SY Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Biophysical mechanisms of phospholipase A2 activation and their use in liposome-based drug delivery
K Jorgensen et al.
FEBS LETTERS (2002)
Phospholipase A2 enzymes
I Kudo et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Matrix metalloproteinases in cancer:: Prognostic markers and therapeutic targets
P Vihinen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma
JZ Jiang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Synthesis of a novel phosphatidylcholine conjugated to docosahexaenoic acid and methotrexate that inhibits cell proliferation
M Zerouga et al.
ANTI-CANCER DRUGS (2002)
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors
D Needham et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells
T Ishida et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2001)
The promise of retinoids to fight against cancer
L Altucci et al.
NATURE REVIEWS CANCER (2001)
Interfacial enzymology:: The secreted phospholipase A2-paradigm
OG Berg et al.
CHEMICAL REVIEWS (2001)
Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum
I Edhemovic et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Gelatin-binding region of human matrix metalloproteinase-2 -: Solution structure, dynamics, and function of the COL-23 two-domain construct
K Briknarová et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phase I-II study of pegylated liposomal cisplatin (SPI-077™) in patients with inoperable head and neck cancer
KJ Harrington et al.
ANNALS OF ONCOLOGY (2001)
Liposome application: problems and prospects
Y Barenholz
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2001)
Docosahexaenoic acid induces apoptosis in Jurkat cells by a protein phosphatase-mediated process
RA Siddiqui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Current status of pH-sensitive liposomes in drug delivery
DC Drummond et al.
PROGRESS IN LIPID RESEARCH (2000)
Share Paper
